Vaccine
    12.
    发明申请
    Vaccine 有权
    疫苗

    公开(公告)号:US20050002956A1

    公开(公告)日:2005-01-06

    申请号:US10706275

    申请日:2003-11-13

    IPC分类号: A61K39/02 A61K39/09

    摘要: Effective stimulation of immune responses is achieved through the use of a group A streptococcal antigen combined with proteosome adjuvant. The compositions are provided in particular for intranasal administration. The vaccine compositions are provided for use in inducing an immune response in an individual for the treatment or prophylaxis of group A streptococcal infection in an individual, preferably via prevention or reduction of colonisation of the throat following intranasal administration.

    摘要翻译: 免疫应答的有效刺激是通过使用A组链球菌抗原与蛋白酶佐剂组合而实现的。 提供了特别用于鼻内给药的组合物。 提供疫苗组合物用于在个体中诱导免疫应答,用于治疗或预防个体中A组链球菌感染,优选通过鼻内施用后预防或减少咽喉的定植。